Remove tag virtual-clinical-trials
article thumbnail

2021 Highlights of Chronic Care Medicine

PharmD Live

Virtual care a boon for underserved chronic care populations. Virtual care, normalized by the pandemic, is now common practice for providers and patients, especially at the primary care level–a boon in 2021 for underserved chronic care populations. The average of the increases is 49%. Aduhelm earns FDA approval. See it here.

FDA 52
article thumbnail

Disruptive Tech in Pharma: A Future of Digital Interactions

Viseven

From AI-based drug discovery to running virtual cohorts for clinical trials or doing continuous manufacturing instead of batch manufacturing, from launching a project effectively to doing real-world tickets, there is technology penetration all along the value chain. And then all the technology will be applied to it.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A roadmap for adopting New Science 

pharmaphorum

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. And 65% of pharma sales rep meetings were held virtually.

article thumbnail

Walking Each Other Home with Community-Based Psychedelic Support

The Spirit Pharmacist

Psychedelic therapies are making headlines due to the unprecedented benefits demonstrated in clinical trials for persons with refractory mental illnesses. However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies.